A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults
NCT07172321
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
PF-08049820 MR1
DRUG:
PF-08049820 MR2
DRUG:
PF-08049820 IR
Sponsor
Pfizer